Effect of differentiation on platelet-activating factor metabolism in HL-60 cells.
The formation and metabolism of 1-O-alkyl-2-acetyl-sn-glycerol (AAG), a protein kinase C (PKC) activator formed from platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3- phosphocholine; PAF), was studied in HL-60 cells to determine whether differentiation may influence this process. HL-60 cells differentiated to macrophages (HL-60/M phi) with a phorbol ester convert added [3H]PAF to AAG; 22% of the incorporated radioactivity is converted to AAG within 15s. By contrast, neither undifferentiated HL-60 cells (HL-60/U) nor HL-60 cells differentiated to granulocytes (HL-60/GN) with retinoic acid produce AAG from PAF. The HL-60/M phi rapidly convert radiolabeled AAG to 1-O-alkyl-sn-glycerol and, subsequently, to two other unidentified metabolites. However, some apparently unmodified AAG persists in the cell lipids for at least 6 h. The HL-60 subtypes which do not convert PAF to AAG can nevertheless catabolize AAG; HL-60/U and HL-60/GN produce alkylglycerol and the other AAG metabolites. These findings demonstrate that differentiation can alter the processing of PAF in a human leukocyte cell line. Furthermore, they suggest that PAF may produce at least some of its biological effects in macrophages by conversion to AAG.
Stoll
L L
LL
Department of Biochemistry, University of Iowa, Iowa City 52242.
Yerram
N R
NR
Spector
A A
AA
D002454:Cell Differentiation; D005995:Glyceryl Ethers / Q000378:metabolism; D006801:Humans; D010641:Phenotype; D010972:Platelet Activating Factor / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D005995:Glyceryl Ethers; D010972:Platelet Activating Factor